Clinical Trial: A New Approach to Treatment of Chronic Migraine

The medical technology firm Boston Scientific Corp. announced the launch of a clinical trial to test the potential effectiveness of their neurostimulation product, PrecisionTM System, as a treatment for chronic migraine. The OPTIMISE trial will employ occipital nerve stimulation with the device in conjunction with administration of anti-migraine medications, and is expected to be used to support various regulatory approvals of this new therapy for migraine. Read a news release on the trial here.


Related Content